{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:10:27Z","timestamp":1790676627704,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>APS is a heterogeneous disease with different phenotypes. Using an unsupervised hierarchical cluster analysis, we aimed to determine distinct homogeneous phenotypes among APS patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed an observational, retrospective study of APS patients enrolled in the French multicentre \u2018APS and SLE\u2019 registry who met the Sydney classification criteria. The clustering process involved an unsupervised multiple correspondence analysis followed by a hierarchical ascendant clustering analysis; it used 27 variables selected to cover a broad range of APS clinical and laboratory manifestations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>These analyses included 509 patients, mainly women (77.8%). Mean (s.d.) age at APS diagnosis was 36.2 (14.6)\u2009years, and mean follow-up since diagnosis 10.3 (8.5)\u2009years. This hierarchical classification cluster analysis yielded four homogeneous groups of patients: cluster 1, mostly with venous thromboembolism without any associated autoimmune disease; cluster 2, older, lowest proportion of women, history of arterial events, and\/or with migraines, arterial hypertension, diabetes mellitus, or dyslipidaemia; cluster 3, younger, highest proportion of women, associated SLE or other autoimmune diseases, and a history of venous thromboembolism or pregnancy morbidity; and cluster 4, mainly with a history of catastrophic antiphospholipid syndrome, aPL-associated nephropathy, and pregnancy morbidity, with frequent triple positivity and more deaths (16.7%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our study applied an unsupervised clustering method to distinguish four homogeneous APS patient subgroups that were predominantly venous; arterial; associated with SLE or another autoimmune disease; and arterial microthrombotic. Heterogeneous pathophysiological mechanisms may explain these findings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac548","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T13:37:12Z","timestamp":1664804232000},"page":"2813-2819","source":"Crossref","is-referenced-by-count":21,"title":["Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-3824","authenticated-orcid":false,"given":"Yann","family":"Nguyen","sequence":"first","affiliation":[{"name":"National Referral Centre for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, H\u00f4pital Cochin, AP-HP Centre, Universit\u00e9 de Paris , Paris, France"},{"name":"Centre de Recherche en Epid\u00e9miologie et Statistiques (CRESS), Unit\u00e9 Inserm 1153, Universit\u00e9 de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile M","family":"Yelnik","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North and North-West of France (CeRAINO), CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE\u2014Institute for Translational Research in Inflammation , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Morel","sequence":"additional","affiliation":[{"name":"National Referral Centre for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, H\u00f4pital Cochin, AP-HP Centre, Universit\u00e9 de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-4157","authenticated-orcid":false,"given":"Romain","family":"Paule","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Foch , Suresnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Stammler","sequence":"additional","affiliation":[{"name":"National Referral Centre for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, H\u00f4pital Cochin, AP-HP Centre, Universit\u00e9 de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Pla\u00e7ais","sequence":"additional","affiliation":[{"name":"National Referral Centre for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, H\u00f4pital Cochin, AP-HP Centre, Universit\u00e9 de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6544-234X","authenticated-orcid":false,"given":"Karim","family":"Sacr\u00e9","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Bichat, AP-HP Nord, Universit\u00e9 de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Godeau","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Mondor, AP-HP, Universit\u00e9 de Paris-Est Cr\u00e9teil , Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Maillard","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North and North-West of France (CeRAINO), CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE\u2014Institute for Translational Research in Inflammation , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North and North-West of France (CeRAINO), CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE\u2014Institute for Translational Research in Inflammation , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Morell-Dubois","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North and North-West of France (CeRAINO), CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE\u2014Institute for Translational Research in Inflammation , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7201-6456","authenticated-orcid":false,"given":"Anastasia","family":"Dupr\u00e9","sequence":"additional","affiliation":[{"name":"National Referral Centre for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, H\u00f4pital Cochin, AP-HP Centre, Universit\u00e9 de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lef\u00e8vre","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North and North-West of France (CeRAINO), CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE\u2014Institute for Translational Research in Inflammation , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Devloo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North and North-West of France (CeRAINO), CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE\u2014Institute for Translational Research in Inflammation , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0559-5798","authenticated-orcid":false,"given":"Virginie","family":"Dufrost","sequence":"additional","affiliation":[{"name":"Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, University of Lorraine, Inserm U1116 , Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ygal","family":"Benhamou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU de Rouen, UniRouen, Inserm, U1096 , Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Levesque","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU de Rouen, UniRouen, Inserm, U1096 , Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Leroux","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Piette","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[{"name":"National Referral Centre for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, H\u00f4pital Cochin, AP-HP Centre, Universit\u00e9 de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Hachulla","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North and North-West of France (CeRAINO), CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE\u2014Institute for Translational Research in Inflammation , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North and North-West of France (CeRAINO), CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE\u2014Institute for Translational Research in Inflammation , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Le Guern","sequence":"additional","affiliation":[{"name":"National Referral Centre for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, H\u00f4pital Cochin, AP-HP Centre, Universit\u00e9 de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[{"name":"National Referral Centre for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, H\u00f4pital Cochin, AP-HP Centre, Universit\u00e9 de Paris , Paris, France"},{"name":"Centre de Recherche en Epid\u00e9miologie et Statistiques (CRESS), Unit\u00e9 Inserm 1153, Universit\u00e9 de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"2023080220581855200_keac548-B1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb. Haemost"},{"key":"2023080220581855200_keac548-B2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"2023080220581855200_keac548-B3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023080220581855200_keac548-B4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","article-title":"Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis","volume":"72","author":"Mahr","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2023080220581855200_keac548-B5","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/art.39790","article-title":"Relapsing polychondritis can be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients","volume":"68","author":"Dion","year":"2016","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"2023080220581855200_keac548-B6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/S0049-0172(03)00133-1","article-title":"Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center","volume":"33","author":"Font","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"2023080220581855200_keac548-B7","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"2023080220581855200_keac548-B8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0961203306075977","article-title":"Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis","volume":"16","author":"Krause","year":"2007","journal-title":"Lupus"},{"key":"2023080220581855200_keac548-B9","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/rheumatology\/kez596","article-title":"Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients","volume":"60","author":"Sciascia","year":"2021","journal-title":"Rheumatology"},{"key":"2023080220581855200_keac548-B10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1177\/0961203320940776","article-title":"Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry","volume":"29","author":"Zuily","year":"2020","journal-title":"Lupus"},{"key":"2023080220581855200_keac548-B11","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1097\/IAE.0000000000003185","article-title":"Catastrophic antiphospholipid syndrome and posterior ocular involvement: case series of 11 patients and literature review","volume":"41","author":"Morel","year":"2021","journal-title":"Retina"},{"key":"2023080220581855200_keac548-B12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.autrev.2018.03.011","article-title":"Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: analysis of a cohort of 214 patients","volume":"17","author":"Paule","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2023080220581855200_keac548-B13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2023080220581855200_keac548-B14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","article-title":"Catastrophic antiphospholipid syndrome: updated diagnostic algorithms","volume":"10","author":"Erkan","year":"2010","journal-title":"Autoimmun Rev"},{"key":"2023080220581855200_keac548-B15","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023080220581855200_keac548-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v061.i06","article-title":"NbClust: an R package for determining the relevant number of clusters in a data set","volume":"61","author":"Charrad","year":"2014","journal-title":"J Stat Softw"},{"key":"2023080220581855200_keac548-B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v070.i01","article-title":"missMDA: a package for handling missing values in multivariate data analysis","volume":"70","author":"Josse","year":"2016","journal-title":"J Stat Softw"},{"key":"2023080220581855200_keac548-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: an R package for multivariate analysis","volume":"25","author":"L\u00ea","year":"2008","journal-title":"J Stat Softw"},{"key":"2023080220581855200_keac548-B19","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.21041","article-title":"Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases","volume":"52","author":"Franc\u00e8s","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023080220581855200_keac548-B20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/rheumatology\/keaa542","article-title":"Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study","volume":"60","author":"Ogata","year":"2021","journal-title":"Rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac548\/46544591\/keac548.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/8\/2813\/51026529\/keac548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/8\/2813\/51026529\/keac548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T20:58:35Z","timestamp":1691009915000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/8\/2813\/6747168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,10,3]]},"published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac548","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8,1]]},"published":{"date-parts":[[2022,10,3]]}}}